HDAC9 and rheumatoid arthritis: Thus, the increased expression of histone deacetylase (HDCA) in PBMCs from RA patients compared to healthy individuals led to the application of HDCA inhibitors with beneficial effects reported on RA development [51], despite the side effects associated with non-selective HDAC inhibitors [52].